Multivariate models | Pain severity | |
---|---|---|
Summated pain score | ||
(0–30) | ||
β | ||
Markers of Disease Activity | DAS28-CRP (0-9.4) | 0.45*** |
US-Combined (0–48) | 0.10 | |
Adjusted R2 | 0.22*** | |
Markers of Disease Activity and Pain Sensitivity | DAS28-CRP (0-9.4) | 0.44*** |
US-Combined (0–48) | 0.12 | |
TS (0–10) | 0.13 | |
CPM (kPa) | -0.14 | |
Adjusted R2 | 0.26*** | |
Discrete Markers of Inflammation and Pain Sensitivity | CRP (mg/l) †| 0.42*** |
SJC (0–28) †| 0.21* | |
US-SH (0–48) †| 0.19 | |
US-PD (0–48) †| -0.08 | |
TS (0–10) | 0.13 | |
CPM (kPa) | -0.02 | |
Adjusted R2 | 0.24*** | |
Markers of Disease Activity Pain Sensitivity and Anthropometric Variables | DAS28-CRP (mg/l) | 0.46*** |
US-Combined (0–48) | 0.11 | |
TS (0–10) | 0.15 | |
CPM (kPa) | -0.13 | |
Age (y) | 0.10 | |
Sex (f) | 0.10 | |
BMI (kg/m2) | -0.02 | |
Adjusted R2 | 0.26*** |